Menstrual migraine: Pathophysiology, diagnosis, and impact

Headache

Volumn 46, Issue SUPPL. 2, 2006, Pages S56-S61

  Loder, Elizabeth W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; Estrogen; Menses; Ovulation

Indexed keywords

ESTROGEN; SEROTONIN AGONIST; TRIPTAN DERIVATIVE;

CONFERENCE PAPER; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; INCIDENCE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE; NOCICEPTION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEROTONINERGIC NERVE CELL;

EID: 33749522559     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00555.x     Document Type: Conference Paper

References (34)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002;346:257-270.
2. Lipton RB, Bigal ME. Migraine: Epidemiology, impact, and risk factors for progression. Headache. 2005;45(suppl 1):S3-S13.
3. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353.
4. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55:1517-1523.
5. Breslau N, Rasmussen BK. The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology. 2001;56(suppl 1):S4-S12.
6. Kornstein SG, Parker AJ. Menstrual migraines: Etiology, treatment, and relationship to premenstrual syndrome. Curr Opin Obstet Gynecol. 1997;9:154-159.
7. Stang PE, Crown WH, Bizier R, Chatterton ML, White R. The family impact and costs of migraine. Am J Manag Care. 2004;10:313-320.
8. Dowson AJ, Kilminster SG, Salt R, Clark M, Bundy MJ. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: A general practice study. Headache. 2005;45:274-282.
9. Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, Brundu B, Facchinetti F, Nappi G. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004;24:707-716.
10. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Results from the American Migraine Study II. Headache. 2001;41:646-657.
11. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999;159:813-818.
12. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: Population-based studies in the USA and UK. Cephalalgia. 2003;23:429-440.
13. International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(suppl 1):1-151.
14. Epstein MT, Hockaday JM, Hockaday TD. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975;1:543-548.
15. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: A clinico-epidemiologic study. Maturitas. 1993;17:31-37.
16. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: Results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. 2005;147:753-760.
17. Silberstein S. Physiology of the menstrual cycle. Cephalalgia. 2000;20:148-154.
18. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
19. Somerville BW. The role of progesterone in menstrual migraine. Neurology. 1971;21:853-859.
20. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology. 1975;25:239-244.
21. Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia. 2000;20:170-174.
22. Pradalier A, Vincent D, Beaulieu P, Baudesson G, Launay J-M. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. Proceedings of the Tenth Migraine Trust International Symposium. 1994:129-132.
23. de Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed). 1986;293:1540.
24. Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: A double-blind trial of percutaneous estradiol. Gynecol Endocrinol. 1988;2:113-120.
25. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part I. Headache. 2006;46:3-23.
26. Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology. 1998;51:307-309.
27. Newman L, Mannix LK, Landy S, Neto W. Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study. Headache. 2001;41:248-256.
28. Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-269.
29. Dawson-Basoa MB, Gintzler AR. 17-β-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res. 1993;601:241-245.
30. Puri V, Cui L, Liverman CS, Roby KF, Klein RM, Welch KM, Berman NE. Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides. 2005;39:409-417.
31. Cahill CA. Beta-endorphin levels during pregnancy and labor: A role in pain modulation? Nurs Res. 1989;38:200-203.
32. Hellström B, Anderberg UM. Pain perception across the menstrual cycle phases in women with chronic pain. Percept Mot Skills. 2003;96:201-211.
33. Rao SS, Ranganekar AG, Saifi AQ. Pain threshold in relation to sex hormones. Indian J Physiol Pharmacol. 1987;31:250-254.
34. MacGregor EA. "Menstrual" migraine: Towards a definition. Cephalalgia. 1996;16:11-21.